ThermoGenesis Holdings Inc. (THMO): Why You Should Keep An Eye On It

0
11
KOSK
KOSK

The stock of ThermoGenesis Holdings Inc. (NASDAQ:THMO) increased by $0.02 on Wednesday to $0.13, up 17.41 percent. The last five days have seen an average of 1,393,319 shares of common stock traded. 3 times new highs were reached in the current year, with a fall of -$0.8833. The average number of shares traded over the last 20 days was 1,992,245, while the average volume over the last 50 days totaled 1,326,882.

THMO stock dropped -51.33% since last month. On 11/11/22, the company’s shares reached a one-month low of $0.0880. The stock touched a high of $1.89 on 01/05/22, after rallying from a low of $0.09 in 52 weeks. The price of THMO stock has declined by -88.91% or -$0.8833 this year, reaching a new high 3 times. Still, the stock price is down -93.04% from the 52-week high.


China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.

Sponsored


Valuation Metrics

Beta for the stock is 2.27. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 0.53, the price-to-book (PB) ratio of 0.70.

Financial Health

For the three months ended September 29, ThermoGenesis Holdings Inc.’s quick ratio was 0.60, while its current ratio was 1.00, indicating its inability to pay off its debt. As far as profitability goes, gross margin for the trailing twelve months is 29.30% percent. ThermoGenesis Holdings Inc.’s operating margin stood at -58.80% for the same period. Based on annual data, it had gross profit of $3.49 million and revenue of $9.29 million.

Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. THMO’s return on assets (ROA) during the last 12 months has been -52.20%. In the meantime, the return on equity (ROE) for the last 12 months was -247.70%.

Earnings Surprise

According to ThermoGenesis Holdings Inc.’s quarterly financial report for the quarter that ended September 29. A lower net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $2.12 million, while revenues fell by -49.06% to $3.03 million. It was predicted that ThermoGenesis Holdings Inc.’s quarterly earnings would be -$0.1, but it ended up being -$0.03, beating the consensus by -233.30%. EBITDA was -$0.82 million for the quarter. At the end of ThermoGenesis Holdings Inc.’s most recent quarter ended September 29, its liabilities totaled 15.83 million, while its total debt was $10.36 million. Equity owned by shareholders amounts to $46.0 million.

Technical Picture

Here’s a quick look at ThermoGenesis Holdings Inc.’s (THMO) price momentum from a technical perspective. As of 22 November, the RSI 9-day stood at 55.51%, suggesting the stock is Neutral, with a 125.11% historical volatility rate.

The stochastic %K and %D were 75.96% and 65.65% respectively, while the average true range (ATR) was 0.0145. Based on the 14-day stochastic reading of 92.58%, the RSI (14) reading is 46.15%. On the 9-day MACD Oscillator, the stock is at 0.0058, and the 14-day reading is at 0.0109.

Analyst Ratings

In its analyst report released on May 23, 2018, H.C. Wainwright began covering ThermoGenesis Holdings Inc. (NASDAQ: THMO). The stock was rated as a Buy by the brokerage firm. Analysts have assigned ThermoGenesis Holdings Inc. (THMO) an Buy rating. THMO is a stock that is recommended for selling by 0 brokerage firms, while 0 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 1 other recommend it as a buy.

LEAVE A REPLY

Please enter your comment!
Please enter your name here